HIV Infection Clinical Trials in Miami, Florida
11 recruitingMiami, Florida
Showing 1–11 of 11 trials
Recruiting
Phase 1Phase 2
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled46 locationsNCT02140255
Recruiting
Not Applicable
The Test-to-PrEP Study
HIV Infections
University of Miami320 enrolled1 locationNCT06927856
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
ViiV Healthcare150 enrolled62 locationsNCT07202546
Recruiting
Not Applicable
Comprehensive HIV and Harm Prevention Via Telehealth
HIV Infections
University of Miami350 enrolled2 locationsNCT05897099
Recruiting
Not Applicable
Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
HIV Infections
University of Miami40 enrolled1 locationNCT06730555
Recruiting
Not Applicable
Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes
HIV Infection Primary
Florida International University66 enrolled1 locationNCT05947266
Recruiting
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Anal CarcinomaMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+9 more
AIDS Malignancy Consortium200 enrolled8 locationsNCT05663502
Recruiting
Not Applicable
Integrated Navigation Services for Treatment Adherence, Counseling, and Research
HIV Infection Primary
University of Miami10 enrolled1 locationNCT04663152
Recruiting
Phase 1Phase 2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
HIV Infections
ViiV Healthcare20 enrolled8 locationsNCT05674656
Recruiting
Not Applicable
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
HIV InfectionsSexually Transmitted Diseases
Public Health Foundation Enterprises, Inc.300 enrolled4 locationsNCT04855773